Evidence map›Paper›PMID 33876818›Full record

ArticleBioscience reports2021

Butyric acid alleviated chronic intermittent hypoxia-induced lipid formation and inflammation through up-regulating HuR expression and inactivating AMPK pathways.

MiaoShang Su, Yifan He, Sichen Xue, Jueke Yu, Xikai Ren, Nan Huang, Rukkaiya Abdullahi, Manhuan Xu

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

MiaoShang SuThe Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Zhejiang 325000, China.
Yifan HeThe Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Zhejiang 325000, China.
Sichen XueThe Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Zhejiang 325000, China.
Jueke YuThe Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Zhejiang 325000, China.
Xikai RenThe Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Zhejiang 325000, China.
Nan HuangThe Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Zhejiang 325000, China.
Rukkaiya AbdullahiThe Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Zhejiang 325000, China.
Manhuan XuLaboratory Medical and Life Science College, Wenzhou Medical University, Zhejiang 325035, China.ORCID 0000-0003-4122-9664
Wenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate whether butyric acid could alleviate chronic intermittent hypoxia (CIH)-induced lipid formation in human preadipocytes-subcutaneous (HPA-s) through accumulation of human antigen R (HuR) and inactivation of AMP-activated protein kinase (AMPK) pathway, HPA-s were obtained and divided into three groups: Control group: cells were cultured under normal conditions; CIH group: cells were cultured in a three-gas incubator (10% O2); Butyric acid group: 10 mmol/l butyric acid added into cell culture medium. HuR-siRNA was futher transfected into CIH group for verification the function of HuR. Oil Red O was implemented for observation of lipid droplets within cells. Cell Counting Kit-8 (CCK8) assay was used for detecting cell viability. Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-nick end labeling (TUNEL) assay as well as flow cytometry analysis was employed for determining cell apoptosis. Western blotting was used for measurement of protein expression levels. RT-qPCR analysis was used for detecting mRNA expression. CIH treatment increased adipocytes proliferation, while butyric acid inhibited cell proliferation and promoted cell apoptosis. The treatment of butyric acid in CIH group down-regulated expression of inflammatory factors and increased cell apoptotic rate. Butyric acid treatment increased HuR expression in both cytoplasm and nucleus and decreased the level of p-AMPK and p-ACC, while transfection of AMPK activator or HuR-siRNA would down-regulate HuR expression. Moreover, butyric acid alleviated CIH-induced cell proliferation, lipid formation and inflammatory status and promoted cell apoptosis through regulating related genes including p21, PPARγ, C/EBPa, IL-1β, IL-6, TLR4, caspase-8 and caspase-3. In conclusion, butyric acid could alleviate CIH-induced inflammation, cell proliferation and lipid formation through accumulation of HuR and inactivation of AMPK pathway.

Indexed as

AdipocytesAMP-Activated Protein KinasesAnti-Inflammatory AgentsApoptosisApoptosis Regulatory ProteinsButyric AcidCell HypoxiaCell ProliferationCells, CulturedELAV-Like Protein 1HumansInflammationInflammation MediatorsLipogenesisSignal TransductionUp-RegulationAMP-Activated Protein KinasesAnti-Inflammatory AgentsApoptosis Regulatory ProteinsButyric AcidELAVL1 protein, humanELAV-Like Protein 1Inflammation MediatorsAMPKbutyric acidchronic intermittent hypoxiahuman antigen Rlipid formation

Identifiers

PMID33876818
PMCPMC8220371
OpenAlexW3152811694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.